AMIT, the Alfred Mann Institute at the Technion is the Technion acceleration hub which supports the development and commercialization of exceptional biomedical innovations conceived by Technion students, faculty and alumni, with a mission to bring to market promising innovative biomedical technologies. Mann, an American entrepreneur and philanthropist, and by the Technion - Israel Institute of Tec
hnology, a leading research university, AMIT aspires to bridge the gap between applied academic research and commercial success. Technion Israel Institute of Technology is renowned for its world class research and its unique entrepreneurial spirit of researchers, students and alumni. It takes great pride in being not only a leading research institute but also a hub for company formation and entrepreneurship. Over two decades, Technion alumni have founded or managed more than 1,600 companies. These have directly created over 100,000 jobs and have been involved in M&A deals exceeding $30B. 50% of Israeli-related companies traded on NASDAQ are either managed or founded Technion alumni.
